Cancer Treatment Centers of America: Clinical Trials
Learn More About This Topic: Chat with Us | Email Us
O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse
Summary
A trial of a vaccine made from the patient's own ovarian tumor to see if this approach might be effective in creating an immune response to the patient's cancer cells.
Requirements
Stage III or IV ovarian cancer
Scheduled for tumor reducing surgery
Good performance status
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
CTCA Facilities Offering This Clinical Trial
Midwestern Regional Medical Center
